ArticleCancer medicine2023

Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approach.

Annarita Fanizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.